Loading...
11 South Korea Developmental Anomalities Reports
Country Covered: South Korea
Study Period: 2021 - 2030
Major Players: DJO Global, Teikoku Pharma, Zimmer Biomet, 3M, AKSIGEN
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Boehringer Ingelheim, UCB, Novartis, Teva Pharmaceutical Industries, Merck
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Ipsen, Merz Pharma, Teva Pharmaceutical Industries, Supernus Pharmaceuticals, Abbvie
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: GlaxoSmithKline, Boehringer Ingelheim, Newron Pharmaceuticals, Roche, Abbvie
Country Covered: South Korea
Study Period: 2021 - 2030
Major Players: Novartis, Bausch Health, REGENXBIO, Roche, Regeneron Pharmaceuticals
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Grünenthal, Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Teva Pharmaceutical Industries
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Medtronic, Piramal Enterprises Ltd, Abbvie, Ipsen, Roche
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Bayer, Nestle, Sanofi, Haleon, Novartis, Zydus Life Sciences Limited, Eli Lilly and Company
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Novartis, Pfizer, Teva Pharmaceutical Industries, Zimmer Biomet, Viatris
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Biogen, Roche, Cytokinetics, Novartis, Catalyst Pharmaceutical
Country Covered: South Korea
Study Period: 2019 - 2030
Major Players: Biogen, Novartis, Merck, Sanofi, Acorda Therapeutics
